Virax Biolabs Group Limited ( VRAX) - Stock Earnings
VRAX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q3 | -2.8 million USD | 4953 USD |
| 2025Q2 | -3.3 million USD | 1378 USD |
| 2025Q3 | -2.3 million USD | 1608 USD |
VRAX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -5.5 million USD | 8561 USD |
| 2024 | -6.7 million USD | 156419 USD |
| 2025 | -6.1 million USD | 6331 USD |
| 2026 Est. | — | — |
VRAX
Price: $1.22
52 week price:
Earnings Per Share: -1.08 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 447900